Literature DB >> 12744467

Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes.

Peter Birner1, Maria Piribauer, Ingeborg Fischer, Brigitte Gatterbauer, Christine Marosi, Peter F Ambros, Inge M Ambros, Markus Bredel, Georg Oberhuber, Karl Rössler, Herbert Budka, Adrian L Harris, Johannes A Hainfellner.   

Abstract

No data exist on angiogenic patterns and their prognostic impact in human glioblastoma. Such data are relevant for translation of antiangiogenic therapies into clinical applications. Using immunohistochemistry for CD34, we assessed vascular patterns in 114 primary glioblastomas. Vascular patterns comprised unevenly distributed glomeruloid/garland-like/clustered bizarre vascular formations and evenly distributed delicate capillary-like microvessels ("classic" vascular pattern). The combination of low content of bizarre vascular formations and prominent classic vascular pattern (n=29) was an independent factor for longer survival (p=0.006, Cox regression), as well as postoperative high Karnofsky performance status (p=0.005). In patients with a prominent classic vascular pattern, there was no difference of MIB1 labeling index whereas microvessel density and apoptotic index (TUNEL) were significantly higher as compared to all other patients (p<0.05). In addition, diffuse expression of hypoxia-inducible factor (HIF)-1alpha and strong expression of vascular endothelial growth factor were more common (p<0.05, Chi-square test). FISH revealed loss of chromosomes 1p and 19q only in 1/7 long-time survivors with classic pattern. We conclude that vascular patterns in primary glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins. Our findings denote for the first time distinct angiogenic subtypes of human glioblastoma which may prove relevant for anti-angiogenic therapy approaches.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12744467     DOI: 10.1111/j.1750-3639.2003.tb00013.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  54 in total

Review 1.  Use of bevacizumab in recurrent glioblastoma.

Authors:  Ashley Ghiaseddin; Katherine B Peters
Journal:  CNS Oncol       Date:  2015-04-23

2.  Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy.

Authors:  C Haberler; E Gelpi; C Marosi; K Rössler; P Birner; H Budka; J A Hainfellner
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

3.  Prognostic marker analysis in pediatric intracranial ependymomas.

Authors:  Roger E McLendon; Eric Lipp; Diane Satterfield; Melissa Ehinger; Alan Austin; Debra Fleming; Kathryn Perkinson; Michaela Lefaivre; David Zagzag; Benjamin Wiener; Sri Gururangan; Herbert Fuchs; Henry S Friedman; James E Herndon; Patrick Healy
Journal:  J Neurooncol       Date:  2015-01-07       Impact factor: 4.130

4.  Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres.

Authors:  Eli E Bar; Alex Lin; Vasiliki Mahairaki; William Matsui; Charles G Eberhart
Journal:  Am J Pathol       Date:  2010-07-29       Impact factor: 4.307

5.  Angiogenic patterns and their quantitation in high grade astrocytic tumors.

Authors:  Suash Sharma; Mehar C Sharma; Deepak Kumar Gupta; Chitra Sarkar
Journal:  J Neurooncol       Date:  2006-06-29       Impact factor: 4.130

6.  High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: tumor-associated neovascularization as a biomarker for patient survival. A preliminary study.

Authors:  Josep Puig; Gerard Blasco; Josep Daunis-I-Estadella; Angel Alberich-Bayarri; Marco Essig; Rajan Jain; Sebastián Remollo; David Hernández; Montserrat Puigdemont; Javier Sánchez-González; Gloria Mateu; Max Wintermark; Salvador Pedraza
Journal:  Neuroradiology       Date:  2015-10-05       Impact factor: 2.804

7.  3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in the Preoperative Evaluation of Gliomas.

Authors:  Q Zeng; B Jiang; F Shi; C Ling; F Dong; J Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2017-07-20       Impact factor: 3.825

8.  Three-dimensional susceptibility-weighted imaging at 7 T using fractal-based quantitative analysis to grade gliomas.

Authors:  Antonio Di Ieva; Sabine Göd; Günther Grabner; Fabio Grizzi; Camillo Sherif; Christian Matula; Manfred Tschabitscher; Siegfrid Trattnig
Journal:  Neuroradiology       Date:  2012-08-18       Impact factor: 2.804

9.  Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases.

Authors:  A S Berghoff; A Ilhan-Mutlu; A Wöhrer; M Hackl; G Widhalm; J A Hainfellner; K Dieckmann; T Melchardt; B Dome; H Heinzl; P Birner; M Preusser
Journal:  Strahlenther Onkol       Date:  2014-02-28       Impact factor: 3.621

10.  High-grade glioma before and after treatment with radiation and Avastin: initial observations.

Authors:  Ingeborg Fischer; Clare H Cunliffe; Robert J Bollo; Shahzad Raza; David Monoky; Luis Chiriboga; Erik C Parker; John G Golfinos; Patrick J Kelly; Edmond A Knopp; Michael L Gruber; David Zagzag; Ashwatha Narayana
Journal:  Neuro Oncol       Date:  2008-08-12       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.